2024 Q3 Form 10-Q Financial Statement

#000162828024037277 Filed on August 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $918.0K $1.031M
YoY Change -54.46% -49.88%
Cost Of Revenue $398.0K $369.0K
YoY Change -11.75% -5.38%
Gross Profit $520.0K $662.0K
YoY Change -66.77% -60.29%
Gross Profit Margin 56.64% 64.21%
Selling, General & Admin $3.312M $13.25M
YoY Change -32.35% 141.9%
% of Gross Profit 636.92% 2001.36%
Research & Development $1.228M $1.148M
YoY Change -47.68% -44.03%
% of Gross Profit 236.15% 173.41%
Depreciation & Amortization $230.0K $226.0K
YoY Change -46.51% -46.82%
% of Gross Profit 44.23% 34.14%
Operating Expenses $4.736M $14.59M
YoY Change -55.52% 75.26%
Operating Profit -$4.216M -$13.93M
YoY Change -53.58% 109.21%
Interest Expense -$222.0K -$749.0K
YoY Change -87.09% -59.47%
% of Operating Profit
Other Income/Expense, Net -$219.0K -$771.0K
YoY Change -87.58% 15.94%
Pretax Income -$4.435M -$14.70M
YoY Change -59.11% 100.74%
Income Tax $0.00 $12.00K
% Of Pretax Income
Net Earnings -$4.435M -$14.71M
YoY Change -57.29% 111.17%
Net Earnings / Revenue -483.12% -1426.77%
Basic Earnings Per Share -$0.13 -$1.05
Diluted Earnings Per Share -$0.13 -$1.05
COMMON SHARES
Basic Shares Outstanding 35.38M shares 9.919M shares
Diluted Shares Outstanding 34.99M shares 14.71M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $511.0K $5.779M
YoY Change -96.21% -63.15%
Cash & Equivalents $511.0K $5.779M
Short-Term Investments
Other Short-Term Assets $2.128M $2.193M
YoY Change 9.18% 0.55%
Inventory $2.730M $2.752M
Prepaid Expenses
Receivables $610.0K $462.0K
Other Receivables $552.0K $526.0K
Total Short-Term Assets $10.13M $15.17M
YoY Change -55.09% -35.92%
LONG-TERM ASSETS
Property, Plant & Equipment $235.0K $225.0K
YoY Change -76.8% -77.7%
Goodwill $12.74M $12.33M
YoY Change
Intangibles $4.778M $4.838M
YoY Change 107.38% 88.03%
Long-Term Investments
YoY Change
Other Assets $878.0K $891.0K
YoY Change 435.37% 412.07%
Total Long-Term Assets $19.15M $18.87M
YoY Change 276.69% 178.81%
TOTAL ASSETS
Total Short-Term Assets $10.13M $15.17M
Total Long-Term Assets $19.15M $18.87M
Total Assets $29.28M $34.04M
YoY Change 5.92% 11.81%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.625M $7.074M
YoY Change 297.14% 324.86%
Accrued Expenses $8.659M $10.63M
YoY Change 142.62% 97.79%
Deferred Revenue $526.0K $464.0K
YoY Change
Short-Term Debt $2.620M $2.504M
YoY Change -76.53% -81.86%
Long-Term Debt Due $2.620M $2.504M
YoY Change -76.53% -81.86%
Total Short-Term Liabilities $22.04M $23.04M
YoY Change 12.57% -2.62%
LONG-TERM LIABILITIES
Long-Term Debt $65.00K $65.00K
YoY Change
Other Long-Term Liabilities $0.00 $0.00
YoY Change -100.0% -100.0%
Total Long-Term Liabilities $65.00K $65.00K
YoY Change -65.43% -73.47%
TOTAL LIABILITIES
Total Short-Term Liabilities $22.04M $23.04M
Total Long-Term Liabilities $65.00K $65.00K
Total Liabilities $22.42M $23.47M
YoY Change 13.42% -1.85%
SHAREHOLDERS EQUITY
Retained Earnings -$79.71M -$75.27M
YoY Change -77.09% -77.7%
Common Stock $38.00K $27.00K
YoY Change -66.07% -37.21%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $6.865M $10.58M
YoY Change
Total Liabilities & Shareholders Equity $29.28M $34.04M
YoY Change 5.92% 11.81%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$4.435M -$14.71M
YoY Change -57.29% 111.17%
Depreciation, Depletion And Amortization $230.0K $226.0K
YoY Change -46.51% -46.82%
Cash From Operating Activities -$6.115M -$5.639M
YoY Change -34.11% -10.52%
INVESTING ACTIVITIES
Capital Expenditures $36.00K $47.00K
YoY Change -62.89% -202.17%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0% -100.0%
Cash From Investing Activities -$36.00K -$47.00K
YoY Change -97.33% -54.81%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 869.0K 9.669M
YoY Change -89.73% 41.65%
NET CHANGE
Cash From Operating Activities -6.115M -5.639M
Cash From Investing Activities -36.00K -47.00K
Cash From Financing Activities 869.0K 9.669M
Net Change In Cash -5.282M 3.983M
YoY Change 144.09% 848.33%
FREE CASH FLOW
Cash From Operating Activities -$6.115M -$5.639M
Capital Expenditures $36.00K $47.00K
Free Cash Flow -$6.151M -$5.686M
YoY Change -34.4% -9.11%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
251000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 usd
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3197771 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3197771 shares
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4629000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6194000 usd
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.05
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.05
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.19
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.19
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14714143 shares
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14714143 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3899102 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3899102 shares
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-14710000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-4629000 usd
us-gaap Net Income Loss
NetIncomeLoss
-17312000 usd
us-gaap Net Income Loss
NetIncomeLoss
-6194000 usd
CY2024Q2 inpx Change In Fair Value Of Convertible Note Receivable
ChangeInFairValueOfConvertibleNoteReceivable
59000 usd
CY2023Q2 inpx Change In Fair Value Of Convertible Note Receivable
ChangeInFairValueOfConvertibleNoteReceivable
0 usd
inpx Change In Fair Value Of Convertible Note Receivable
ChangeInFairValueOfConvertibleNoteReceivable
59000 usd
inpx Change In Fair Value Of Convertible Note Receivable
ChangeInFairValueOfConvertibleNoteReceivable
0 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-32000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-198000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0 usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14683000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4629000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17451000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6194000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-31629000 usd
CY2024Q1 inpx Stock Issued During Period Value Inducement Loss On Debt Conversions
StockIssuedDuringPeriodValueInducementLossOnDebtConversions
6732000 usd
CY2024Q1 inpx Stock Issued During Period Value Issued For Cashless Exercise Of Warrants
StockIssuedDuringPeriodValueIssuedForCashlessExerciseOfWarrants
0 usd
CY2024Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
61000 usd
CY2024Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
250000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-14982000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
141000 usd
CY2023Q1 inpx Adjustments To Additional Paid In Capital Warrants Issued With Convertible Note
AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedWithConvertibleNote
39000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1565000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-16367000 usd
CY2023Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
12853 shares
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
180000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
2461000 usd
CY2023Q2 inpx Adjustments To Additional Paid In Capital Warrants Issued With Convertible Note
AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedWithConvertibleNote
928000 usd
CY2023Q2 inpx Adjustments To Additional Paid In Capital Joint Venture Obligation Reclassified To Equity
AdjustmentsToAdditionalPaidInCapitalJointVentureObligationReclassifiedToEquity
5583000 usd
CY2023Q2 inpx Adjustments To Additional Paid In Capital Joint Venture Obligation Reclassified To Equity
AdjustmentsToAdditionalPaidInCapitalJointVentureObligationReclassifiedToEquity
5583000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-4629000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-11844000 usd
us-gaap Net Income Loss
NetIncomeLoss
-17312000 usd
us-gaap Net Income Loss
NetIncomeLoss
-6194000 usd
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
47000 usd
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
5000 usd
inpx Amortization Of Intangible Assets Including Other Amortization
AmortizationOfIntangibleAssetsIncludingOtherAmortization
235000 usd
inpx Amortization Of Intangible Assets Including Other Amortization
AmortizationOfIntangibleAssetsIncludingOtherAmortization
13000 usd
inpx Amortization Of Deferred Loan Costs
AmortizationOfDeferredLoanCosts
17000 usd
inpx Amortization Of Deferred Loan Costs
AmortizationOfDeferredLoanCosts
44000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
92000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
0 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
156000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
5733000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2602000 usd
inpx Change In Fair Value Of Joint Venture Obligation
ChangeInFairValueOfJointVentureObligation
0 usd
inpx Change In Fair Value Of Joint Venture Obligation
ChangeInFairValueOfJointVentureObligation
197000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
inpx Change In Fair Value Of Convertible Notes
ChangeInFairValueOfConvertibleNotes
12882000 usd
inpx Change In Fair Value Of Convertible Notes
ChangeInFairValueOfConvertibleNotes
0 usd
inpx Inducement Loss On Debt Conversions
InducementLossOnDebtConversions
6732000 usd
inpx Inducement Loss On Debt Conversions
InducementLossOnDebtConversions
0 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
281000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
126000 usd
inpx Change In Fair Value Of Warrant Asset Cash Flows
ChangeInFairValueOfWarrantAssetCashFlows
-24000 usd
inpx Change In Fair Value Of Warrant Asset Cash Flows
ChangeInFairValueOfWarrantAssetCashFlows
0 usd
inpx Unrealized Gain Loss On Foreign Currency Transactions
UnrealizedGainLossOnForeignCurrencyTransactions
131000 usd
inpx Unrealized Gain Loss On Foreign Currency Transactions
UnrealizedGainLossOnForeignCurrencyTransactions
0 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
93000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
0 usd
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-309000 usd
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-114000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-132000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
0 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-162000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-29000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-8000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
0 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
1981000 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
727000 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
0 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
59000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
6494000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
206000 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
86000 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
248000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-354000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 usd
inpx Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-94000 usd
inpx Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
0 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8190000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1573000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
18000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 usd
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
2968000 usd
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
0 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
39000 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2911000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
180000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
2000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
8547000 usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0 usd
us-gaap Proceeds From Unsecured Notes Payable
ProceedsFromUnsecuredNotesPayable
2000000 usd
us-gaap Proceeds From Unsecured Notes Payable
ProceedsFromUnsecuredNotesPayable
575000 usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
1012000 usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
0 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
750000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
502000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
10000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
11059000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1495000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-6000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5774000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-78000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
115000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5779000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
37000 usd
us-gaap Interest Paid Net
InterestPaidNet
32000 usd
us-gaap Interest Paid Net
InterestPaidNet
1000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
inpx Common Shares Issued For Conversion Of Debt And Accrued Interest
CommonSharesIssuedForConversionOfDebtAndAccruedInterest
9614000 usd
inpx Common Shares Issued For Conversion Of Debt And Accrued Interest
CommonSharesIssuedForConversionOfDebtAndAccruedInterest
0 usd
inpx Common Shares Issued For Exchange Of Warrants
CommonSharesIssuedForExchangeOfWarrants
1698000 usd
inpx Common Shares Issued For Exchange Of Warrants
CommonSharesIssuedForExchangeOfWarrants
0 usd
inpx Deemed Dividend Related To December2023 Warrant Exchange
DeemedDividendRelatedToDecember2023WarrantExchange
283000 usd
inpx Deemed Dividend Related To December2023 Warrant Exchange
DeemedDividendRelatedToDecember2023WarrantExchange
0 usd
inpx Common Shares Issued As Settlement Of Accrued Compensation
CommonSharesIssuedAsSettlementOfAccruedCompensation
1192000 usd
inpx Common Shares Issued As Settlement Of Accrued Compensation
CommonSharesIssuedAsSettlementOfAccruedCompensation
0 usd
inpx Common Shares Issued As Prepayment For Marketing Services
CommonSharesIssuedAsPrepaymentForMarketingServices
335000 usd
inpx Common Shares Issued As Prepayment For Marketing Services
CommonSharesIssuedAsPrepaymentForMarketingServices
0 usd
inpx Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Merger Consideration Issued
NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentMergerConsiderationIssued
22637000 usd
inpx Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Merger Consideration Issued
NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentMergerConsiderationIssued
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
394000 usd
inpx Forgiveness Of Related Party Payable
ForgivenessOfRelatedPartyPayable
380000 usd
inpx Forgiveness Of Related Party Payable
ForgivenessOfRelatedPartyPayable
0 usd
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
311000 usd
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
0 usd
inpx Deemed Dividend Related To Series9 Preferred Stock Exchange
DeemedDividendRelatedToSeries9PreferredStockExchange
177000 usd
inpx Deemed Dividend Related To Series9 Preferred Stock Exchange
DeemedDividendRelatedToSeries9PreferredStockExchange
0 usd
inpx Atm Proceeds Withheld As Payment Towards Accounts Payable
ATMProceedsWithheldAsPaymentTowardsAccountsPayable
128000 usd
inpx Atm Proceeds Withheld As Payment Towards Accounts Payable
ATMProceedsWithheldAsPaymentTowardsAccountsPayable
0 usd
inpx Warrants Issued With Convertible Notes
WarrantsIssuedWithConvertibleNotes
0 usd
inpx Warrants Issued With Convertible Notes
WarrantsIssuedWithConvertibleNotes
967000 usd
inpx Warrants Issued With Common Stock
WarrantsIssuedWithCommonStock
0 usd
inpx Warrants Issued With Common Stock
WarrantsIssuedWithCommonStock
98000 usd
inpx Reclassification Of Joint Venture Obligation To Equity
ReclassificationOfJointVentureObligationToEquity
0 usd
inpx Reclassification Of Joint Venture Obligation To Equity
ReclassificationOfJointVentureObligationToEquity
5583000 usd
CY2024Q2 inpx Working Capital Surplus Deficiency
WorkingCapitalSurplusDeficiency
-7900000 usd
CY2024Q2 us-gaap Cash
Cash
5800000 usd
us-gaap Net Income Loss
NetIncomeLoss
-17300000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8200000 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Use of Estimates</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during each of the reporting periods. Actual results could differ from those estimates. The Company’s significant estimates consist of:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the valuation of stock-based compensation;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">the valuation of the Company’s common stock issued and assets acquired in transactions, including acquisitions;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the valuation of equity securities;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the valuation of notes receivable;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the valuation of warrant liabilities and assets;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the valuation of convertible notes, at fair value;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the valuation of loan conversion derivatives; and</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the valuation allowance for deferred tax assets.</span></div>
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
inpx Revenue From Contract With Customer Stated Term
RevenueFromContractWithCustomerStatedTerm
P1Y
CY2024Q2 inpx Share Based Payment Arrangement Expense Professional Fees
ShareBasedPaymentArrangementExpenseProfessionalFees
0 usd
CY2023Q2 inpx Share Based Payment Arrangement Expense Professional Fees
ShareBasedPaymentArrangementExpenseProfessionalFees
0 usd
inpx Share Based Payment Arrangement Expense Professional Fees
ShareBasedPaymentArrangementExpenseProfessionalFees
5153000 usd
inpx Share Based Payment Arrangement Expense Professional Fees
ShareBasedPaymentArrangementExpenseProfessionalFees
0 usd
CY2024Q2 inpx Share Based Payment Arrangement Expense Including Professional Fees
ShareBasedPaymentArrangementExpenseIncludingProfessionalFees
-59000 usd
CY2023Q2 inpx Share Based Payment Arrangement Expense Including Professional Fees
ShareBasedPaymentArrangementExpenseIncludingProfessionalFees
2461000 usd
inpx Share Based Payment Arrangement Expense Including Professional Fees
ShareBasedPaymentArrangementExpenseIncludingProfessionalFees
5733000 usd
inpx Share Based Payment Arrangement Expense Including Professional Fees
ShareBasedPaymentArrangementExpenseIncludingProfessionalFees
2602000 usd
CY2024Q2 inpx Share Based Payment Arrangement Forfeiture Exceeded Expense
ShareBasedPaymentArrangementForfeitureExceededExpense
59000000 usd
CY2024Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4127977 shares
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1976312 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3354216 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1820876 shares
CY2024Q2 inpx Class Of Warrant Or Right Number Of Weighted Average Penny Warrants
ClassOfWarrantOrRightNumberOfWeightedAveragePennyWarrants
209688 shares
CY2023Q2 inpx Class Of Warrant Or Right Number Of Weighted Average Penny Warrants
ClassOfWarrantOrRightNumberOfWeightedAveragePennyWarrants
608528 shares
CY2024Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.01
inpx Class Of Warrant Or Right Number Of Weighted Average Penny Warrants
ClassOfWarrantOrRightNumberOfWeightedAveragePennyWarrants
608528 shares
inpx Class Of Warrant Or Right Number Of Weighted Average Penny Warrants
ClassOfWarrantOrRightNumberOfWeightedAveragePennyWarrants
608528 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
298395 shares
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
298395 shares
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
298395 shares
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1031000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1251000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1031000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1251000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 usd
CY2024Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 usd
CY2023Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
600000 usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
6500000 usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
700000 usd
CY2024Q2 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
1031000 usd
CY2023Q2 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
820000 usd
CY2024Q2 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-15420000 usd
CY2023Q2 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-9168000 usd
CY2024Q2 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
-1.05
CY2024Q2 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
-1.05
CY2023Q2 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
-0.91
CY2023Q2 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
-0.91
CY2024Q2 us-gaap Weighted Average Basic Shares Outstanding Pro Forma
WeightedAverageBasicSharesOutstandingProForma
14714143 shares
CY2024Q2 us-gaap Pro Forma Weighted Average Shares Outstanding Diluted
ProFormaWeightedAverageSharesOutstandingDiluted
14714143 shares
CY2023Q2 us-gaap Weighted Average Basic Shares Outstanding Pro Forma
WeightedAverageBasicSharesOutstandingProForma
10068967 shares
CY2023Q2 us-gaap Pro Forma Weighted Average Shares Outstanding Diluted
ProFormaWeightedAverageSharesOutstandingDiluted
10068967 shares
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
1758000 usd
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
2727000 usd
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-31669000 usd
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-18453000 usd
us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
-2.15
us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
-2.15
us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
-1.83
us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
-1.83
us-gaap Pro Forma Weighted Average Shares Outstanding Diluted
ProFormaWeightedAverageSharesOutstandingDiluted
14714143 shares
us-gaap Weighted Average Basic Shares Outstanding Pro Forma
WeightedAverageBasicSharesOutstandingProForma
14714143 shares
us-gaap Pro Forma Weighted Average Shares Outstanding Diluted
ProFormaWeightedAverageSharesOutstandingDiluted
10068967 shares
us-gaap Weighted Average Basic Shares Outstanding Pro Forma
WeightedAverageBasicSharesOutstandingProForma
10068967 shares
CY2024Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
5228000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
390000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4838000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
421000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
155000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
266000 usd
CY2024Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
190000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
230000 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10000.00 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10000.00 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
384000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
849000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
849000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
849000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
768000 usd
CY2024Q2 inpx Finite Lived Intangible Asset Expected Amortization After Year Four And Thereafter
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFourAndThereafter
1139000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4838000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
0 usd
CY2024Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
29000 usd
CY2024Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
120000 usd
CY2024Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2603000 usd
CY2024Q2 us-gaap Inventory Gross
InventoryGross
2752000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
0 usd
CY2024Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
500000 usd
CY2024Q2 inpx Transaction Bonus Expense
TransactionBonusExpense
6731000 usd
CY2023Q4 inpx Accrued Transaction Bonus Expense
AccruedTransactionBonusExpense
0 usd
CY2024Q2 inpx Accrued Compensation And Employee Benefits Current
AccruedCompensationAndEmployeeBenefitsCurrent
1959000 usd
CY2023Q4 inpx Accrued Compensation And Employee Benefits Current
AccruedCompensationAndEmployeeBenefitsCurrent
649000 usd
CY2024Q2 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
947000 usd
CY2023Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
305000 usd
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
648000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
173000 usd
CY2024Q2 inpx Accrued Consulting Fees
AccruedConsultingFees
329000 usd
CY2023Q4 inpx Accrued Consulting Fees
AccruedConsultingFees
0 usd
CY2024Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
15000 usd
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
0 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10629000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1127000 usd
CY2024Q2 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
500000 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
50000 usd
CY2024Q2 inpx Debt Instrument Unamortized Loan Costs Current
DebtInstrumentUnamortizedLoanCostsCurrent
0 usd
CY2023Q4 inpx Debt Instrument Unamortized Loan Costs Current
DebtInstrumentUnamortizedLoanCostsCurrent
35000 usd
CY2024Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
2504000 usd
CY2023Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
6690000 usd
CY2024Q2 us-gaap Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
0 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
1210000 usd
CY2024Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
65000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
18546000 usd
CY2024Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
200000 usd
CY2023Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
300000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
600000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
500000 usd
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q1 inpx Preferred Stock Annual Rate Of Return
PreferredStockAnnualRateOfReturn
0.10
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
inpx Share Based Compensation Arrangement By Share Based Payment Award Number Of Incentive Plans
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfIncentivePlans
3 incentive_plan
CY2024Q2 inpx Share Based Compensation Options Grant Exercise Price Limit Of Fair Value
ShareBasedCompensationOptionsGrantExercisePriceLimitOfFairValue
1
CY2024Q2 inpx Share Based Compensation Options Grant Exercise Price Limit Of Fair Value10 Percent Owner
ShareBasedCompensationOptionsGrantExercisePriceLimitOfFairValue10PercentOwner
1.10
CY2024Q2 inpx Aggregate Number Of Shares Available For Future Grant Under Stock Option Plan
AggregateNumberOfSharesAvailableForFutureGrantUnderStockOptionPlan
52773015 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1161687 shares
inpx Share Based Compensation Arrangement By Share Based Payment Award Options Stock Options From Merger In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsStockOptionsFromMergerInPeriodGross
1148 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
11373730 shares
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
92728 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
731 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
118709 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
12324397 shares
CY2024Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
112360 shares
CY2024Q2 inpx Stock Issued During Period Value Warrant Exchange
StockIssuedDuringPeriodValueWarrantExchange
106742 usd
CY2024Q2 inpx Stock Issued During Period Value Warrant Exchange
StockIssuedDuringPeriodValueWarrantExchange
106742 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12000.000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16000.000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-13927000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4041000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-22804000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-5324000 usd
CY2024Q2 us-gaap Assets
Assets
34041000 usd
CY2023Q4 us-gaap Assets
Assets
509000 usd
CY2024Q2 us-gaap Receivables Fair Value Disclosure
ReceivablesFairValueDisclosure
3462000 usd
CY2024Q2 inpx Warrant Fair Value Disclosure
WarrantFairValueDisclosure
424000 usd
CY2024Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
3886000 usd
CY2023Q4 inpx Warrant Liability Fair Value Disclosure
WarrantLiabilityFairValueDisclosure
497000 usd
CY2023Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
16804000 usd
CY2023Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
333000 usd
CY2023Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
17634000 usd
CY2024Q2 us-gaap Revenues
Revenues
1031000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-13927000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
-14710000 usd
CY2023Q2 us-gaap Revenues
Revenues
0 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4041000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
-4629000 usd
us-gaap Revenues
Revenues
1251000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-22804000 usd
us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
-17312000 usd
us-gaap Revenues
Revenues
0 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-5324000 usd
us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
-6194000 usd
CY2024Q2 us-gaap Assets
Assets
34041000 usd
CY2024Q2 us-gaap Noncurrent Assets
NoncurrentAssets
5646000 usd
CY2024Q2 us-gaap Goodwill
Goodwill
12330000 usd
CY2023Q4 us-gaap Assets
Assets
509000 usd
CY2023Q4 us-gaap Noncurrent Assets
NoncurrentAssets
278000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
0 usd
CY2024Q2 inpx Operating Lease Accumulated Amortization
OperatingLeaseAccumulatedAmortization
96000 usd
CY2023Q4 inpx Operating Lease Accumulated Amortization
OperatingLeaseAccumulatedAmortization
0 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
583000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0 usd
CY2024Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
101000 usd
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
1000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
144000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
2000 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
594000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
0 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
235000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
359000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
157000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
220000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
159000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
124000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
10000 usd
CY2024Q2 inpx Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
0 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
670000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
76000 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
594000 usd
CY2024Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y9M18D
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.067
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P1Y
CY2024Q2 inpx Transaction Bonus Expense Accrual Percentage
TransactionBonusExpenseAccrualPercentage
1
CY2024Q2 inpx Transaction Bonus Expense
TransactionBonusExpense
6700000 usd
inpx Transaction Bonus Expense
TransactionBonusExpense
6700000 usd
CY2024Q2 inpx Accrued Transaction Bonus Expense
AccruedTransactionBonusExpense
6700000 usd
CY2024Q2 inpx Financing Receivable And Warrant Asset
FinancingReceivableAndWarrantAsset
3900000 usd
CY2024Q2 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
3500000 usd
CY2024Q2 inpx Warrant Asset Current
WarrantAssetCurrent
400000 usd
CY2024Q2 inpx Transaction Bonus Expense
TransactionBonusExpense
6700000 usd
inpx Transaction Bonus Expense
TransactionBonusExpense
6700000 usd
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
35380840 shares
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001628280-24-037277-index-headers.html Edgar Link pending
0001628280-24-037277-index.html Edgar Link pending
0001628280-24-037277.txt Edgar Link pending
0001628280-24-037277-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
inpx-20240630.htm Edgar Link pending
inpx-20240630.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
inpx-20240630_cal.xml Edgar Link unprocessable
inpx-20240630_def.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
inpx-20240630_pre.xml Edgar Link unprocessable
inpx-20240630_htm.xml Edgar Link completed
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
xti10q-2024q2xex311sp.htm Edgar Link pending
xti10q-2024q2xex312bm.htm Edgar Link pending
xti10q-2024q2xex321.htm Edgar Link pending
inpx-20240630_lab.xml Edgar Link unprocessable